Den europeiske union - norsk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals for felidae, - katter - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

Norge - norsk - Statens legemiddelverk

orifarm as - felint rhinotrakeittvirus virus, stamme fhv f2, levende / felint calicivirus, stamme 431 og g1, inaktivert / felint panleukopenivirus, levende - lyofilisat og væske til injeksjonsvæske, suspensjon